IHS Chemical Week

Chemical Week Magazine :: Newsbriefs

DSM, JLL form $2-billion pharma services firm

6:52 AM MST | November 22, 2013

DSM and private equity firm JLL Partners (New York) have agreed to form a global contract development and manufacturing organization for the pharmaceutical industry, with anticipated sales of about $2 billion in 2014. The company will be formed by combining DSM Pharmaceutical Products (Parsippany, NJ), the custom manufacturing and technology business of DSM, with Patheon (Toronto), a portfolio company of JLL. The new company will be 51% owned by JLL and 49% by DSM. The transaction is expected to close in the first half of 2014. DSM will deconsolidate DSM...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa